These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18661871)

  • 21. Revolutionizing fast disintegrating tablets: Harnessing a dual approach with porous starch and sublimation technique.
    Nadaf SJ; Savekar PL; Bhagwat DA; Dagade KV; Gurav SS
    Heliyon; 2024 Oct; 10(19):e38793. PubMed ID: 39430475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of Losartan Orally Disintegrating Tablets by Direct Compression: a Cost-Effective Approach to Improve Paediatric Patient's Compliance.
    Juan C; Gallo L; Gonzalez Vidal N
    AAPS PharmSciTech; 2024 Apr; 25(4):79. PubMed ID: 38589718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formulation and evaluation of rapidly disintegrating fenoverine tablets: effect of superdisintegrants.
    Battu SK; Repka MA; Majumdar S; Madhusudan RY
    Drug Dev Ind Pharm; 2007 Nov; 33(11):1225-32. PubMed ID: 18058319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenylalanine-free taste-masked orodispersible tablets of fexofenadine hydrochloride: development, in vitro evaluation and in vivo estimation of the drug pharmacokinetics in healthy human volunteers.
    Yehia SA; El-Ridi MS; Tadros MI; El-Sherif NG
    Pharm Dev Technol; 2015; 20(5):528-39. PubMed ID: 24490806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulation and optimization of orodispersible tablets of diazepam.
    Abed KK; Hussein AA; Ghareeb MM; Abdulrasool AA
    AAPS PharmSciTech; 2010 Mar; 11(1):356-61. PubMed ID: 20232267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and evaluation of fast-dissolving tablets of meloxicam-β-cyclodextrin complex prepared by direct compression.
    Obaidat AA; Obaidat RM
    Acta Pharm; 2011 Mar; 61(1):83-91. PubMed ID: 21406346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY; Lin KH; Li MJ
    J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization, optimisation and process robustness of a co-processed mannitol for the development of orally disintegrating tablets.
    Soh JL; Grachet M; Whitlock M; Lukas T
    Pharm Dev Technol; 2013 Feb; 18(1):172-85. PubMed ID: 22582882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formulation and evaluation of taste-masked levocetirizine dihydrochloride orally disintegrating tablets.
    Devireddy SR; Gonugunta CS; Veerareddy PR
    PDA J Pharm Sci Technol; 2009; 63(6):521-6. PubMed ID: 20169858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spray dried excipient base: a novel technique for the formulation of orally disintegrating tablets.
    Mishra DN; Bindal M; Singh SK; Vijaya Kumar SG
    Chem Pharm Bull (Tokyo); 2006 Jan; 54(1):99-102. PubMed ID: 16394558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesoporous Pravastatin Solid Dispersion Granules Incorporable Into Orally Disintegrating Tablets.
    Song H; Moon C; Lee BJ; Oh E
    J Pharm Sci; 2018 Jul; 107(7):1886-1895. PubMed ID: 29530714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formulation Design and Optimization of Orodispersible Tablets of Quetiapine Fumarate by Sublimation Method.
    Kalyankar P; Panzade P; Lahoti S
    Indian J Pharm Sci; 2015; 77(3):267-73. PubMed ID: 26180271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
    Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
    Int J Pharm; 2009 Dec; 382(1-2):80-7. PubMed ID: 19686825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formulation and optimization of orally disintegrating tablets of sumatriptan succinate.
    Sheshala R; Khan N; Darwis Y
    Chem Pharm Bull (Tokyo); 2011; 59(8):920-8. PubMed ID: 21804234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microwave-Assisted Development of Orally Disintegrating Tablets by Direct Compression.
    Kande KV; Kotak DJ; Degani MS; Kirsanov D; Legin A; Devarajan PV
    AAPS PharmSciTech; 2017 Aug; 18(6):2055-2066. PubMed ID: 27995465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orally-disintegrating Tablets in Fixed-dose Combination Containing Ambroxol Hydrochloride and Salbutamol Sulphate Prepared by Direct Compression: Formulation Design, Development and
    Sharma D; Singh R; Singh G
    Turk J Pharm Sci; 2018 Apr; 15(1):29-37. PubMed ID: 32454637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and Optimization by Quality by Design Strategies of Frovatriptan Orally Disintegrating Tablets for Migraine Management.
    Mennini N; Orlandini S; Furlanetto S; Pasquini B; Mura P
    Curr Drug Deliv; 2018; 15(3):436-445. PubMed ID: 28595529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and evaluation of microwave-treated orally disintegrating tablets containing polymeric disintegrant and mannitol.
    Sano S; Iwao Y; Noguchi S; Kimura S; Itai S
    Int J Pharm; 2013 May; 448(1):132-41. PubMed ID: 23524122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formulation and characterization of oral rapid disintegrating tablets of levocetirizine.
    Samvedna S; Jindal S; Mishra G; Madan JR; Gupta G; Awasthi R; Pinto TJA; Dua K; Kulkarni GT
    Polim Med; 2018; 48(1):31-40. PubMed ID: 30657656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formulation and in vivo evaluation of ondansetron orally disintegrating tablets using different superdisintegrants.
    Sheshala R; Khan N; Chitneni M; Darwis Y
    Arch Pharm Res; 2011 Nov; 34(11):1945-56. PubMed ID: 22139694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.